VAERS Explorer
Back to explore

Report #2827713

Received Feb 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
75 yrs
State
IL
Recovered
Not recovered
Vaccinated
Sep 30, 2024
Onset
Oct 1, 2024
Days to onset
1
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
FLU3INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE)SANOFI PASTEURUNK—OT / LA

Symptoms (1)

Rash

Symptom narrative

rash breakout; Initial information received on 12-Feb-2025 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional(Patient). This case involves a 75 years old male patient who experienced rash breakout after receiving Influenza Usp Trival A-B High Dose Subvirion Vaccine [Fluzone Hd]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Varicella zoster vaccine rgE (CHO) (Shingrix) for Immunisation. On 30-Sep-2024, the patient received a unknown dose of suspect Influenza Usp Trival A-B High Dose Subvirion Vaccine (Suspension for injection in pre-filled syringe) strength, expiry date, lot number not reported via unknown route in the upper left arm for Influenza. The information on batch number corresponding to the one at time of event occurrence was requested. On an unknown date in OCT-2024 the patient developed rash breakout (rash) (latency: 1 week approximately) following the administration of Influenza Usp Trival A-B High Dose Subvirion Vaccine. Reportedly "Doctor prescribed them antibiotics but information regarding the antibiotics was not available. When this did not work, they started seeing a dermatologist who prescribed them with clobetasol. They said that this did not work as well so they were prescribed this time with Prednisone. For a while, this worked but whenever the Prednisone was tapered, their rashes would return. They were prescribed on a higher dose but the same pattern repeats. Now, they are being considered for the use of Dupixent.They said that they have been dealing with these rash breakouts for four months now. " Action taken was not applicable. The patient was treated with Clobetasol propionate (Clobetasol) and Prednisone. At time of reporting, the outcome was Not Recovered / Not Resolved for the event rash breakout.

Other medications

Shingrix